"At Ascension Providence Cancer Center in Southfield, Michigan, our doctors and nurses listen to understand your questions and concerns and provide answers to your questions. Then we deliver a care plan with cancer-fighting treatments and support programs. Our medical, radiation and surgical oncologists, oncology-certified nurses, palliative care specialists, genetic counselors, dietitians, and rehabilitation therapists focus on your needs. We’re dedicated to helping you defeat cancer."

During the past decade, Providence Cancer Institute at Providence Hospital - Southfield Campus conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 51 clinical trials were completed, i.e. on average, 255% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 24 clinical trials were completed. i.e. 800% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Cancer Institute at Providence Hospital - Southfield Campus" #1 sponsor was "SWOG Cancer Research Network" with 44 trials, followed by "NSABP Foundation Inc" with 10 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "National Cancer Institute (NCI)" with 6 trials sponsored and "Bristol-Myers Squibb" with 6 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Cancer Institute at Providence Hospital - Southfield Campus" #1 collaborator was "National Cancer Institute (NCI)" with 71 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "NRG Oncology" with 3 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Providence Cancer Institute at Providence Hospital - Southfield Campus" are "Breast Cancer" (23 trials), "Lung Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Leukemia" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Providence Cancer Institute at Providence Hospital - Southfield Campus" in a lesser frequency.

Most popular intervention types in "Providence Cancer Institute at Providence Hospital - Southfield Campus" are "Drug" (89 trials), "Other" (30 trials), "Biological" (24 trials), "Procedure" (14 trials) and "Radiation" (14 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (17 trials), "cyclophosphamide" (9 trials), "radiation therapy" (9 trials), "placebo" (7 trials) and "Dexamethasone" (6 trials). Other intervention names were less common.

The vast majority of trials in "Providence Cancer Institute at Providence Hospital - Southfield Campus" are 78 trials for "All" genders, 23 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Cancer Institute at Providence Hospital - Southfield Campus". undefined are not yet recruiting, 2 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 78 completed trials in Providence Cancer Institute at Providence Hospital - Southfield Campus, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Cancer Institute at Providence Hospital - Southfield Campus, 3 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".